Skip to Content

Haw Par Corp Ltd HAWPF Stock Quote

| Rating as of

Morningstar‘s Stock Analysis HAWPF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics HAWPF

Company Profile HAWPF

Business Description

Haw Par Corp Ltd is a major drug manufacturing company that operates multiple brands. The company's primary strategy is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Geographically, it generates a majority of its revenue from the ASEAN countries.

401 Commonwealth Drive, No. 03-03 Haw Par Technocentre
Singapore, 149598, Singapore
T +65 63379102
Industry Drug Manufacturers - General
Most Recent Earnings Dec 31, 2019
Fiscal Year End Dec 31, 2022
Stock Type
Employees 595